The effect of long-term traditional Chinese medicine treatment on disease-free survival of postoperative stage I-III lung cancer patients: a retrospective cohort study
Journal Title: Traditional Medicine Research - Year 2019, Vol 4, Issue 2
Abstract
Objective: Traditional Chinese medicine (TCM) has been extensively used as one of popular alternative therapies for several cancers. However, it remains unclear whether TCM treatment is associated with longer survival in lung cancer patients. In this study, we explored the effect of long-term TCM treatment on patients with different stages of lung cancer. Methods: All information of lung cancer patients with stage I-III disease from January 2007 to September 2015 was collected for this retrospective cohort study. Those who were treated with TCM after surgery were divided into TCM group and the others were into the non-TCM group (control group). All patients were regularly followed up by clinic appointment or phone, and all survival data were collected from databases after the last follow-up in October 2017. Results: A total of 575 patients were included in this study, with 299 patients in the TCM group and 276 in the control group. For all patients, 5-year disease-free survival (DFS) was 62.2% in TCM group and 42.1% in the control group, and 6-year DFSs were 51.8% and 35.4%, respectively (HR = 0.51, 95% CI: 0.40 to 0.66, log-rank P ≤ 0.001). For patients with stage I, 5-year DFSs were 83.7% (TCM group) and 57.5% (control group) and 6-year DFSs were 73.7% and 51.9%, respectively (HR = 0.30, 95% CI: 0.18 to 0.50, log-rank P ≤ 0.001). For patients with stage II in the TCM group and the control group, 5-year DFSs were 59.4% and 17.6% and 6-year DFSs were 44.7% and 17.6%, respectively (HR = 0.31, 95% CI: 0.19 to 0.52, log-rank P ≤ 0.001), and for patients with stage III, 5-year and 6-year DFSs in the TCM group were 18.7% and 12.5% compared with 28.4% and 20.3% in the control group (HR = 1.06, 95% CI: 0.72 to 1.56, log-rank P = 0.76). Conclusions: This study demonstrated that long-term TCM treatment as an adjuvant therapy is able to improve the DFS of postoperative stage I-III lung cancer patients, especially in patients with stage I and II disease. However, these observational findings need being validated by large sample randomized controlled trials.
Authors and Affiliations
Su-Tong Liu, Su-Fang Zhang,Kai-Qi Su, Ying-Bin Luo, Zhi-Hong Fang, Yuan Fang, Jing Xu, Jian-Chun Wu,Yan Li
India’s indigenous idea of herd immunity: the solution for COVID-19?
Based on folklore and traditional wisdom, when a shepherd purchases a few new sheep from an unknown seller or from a distant place, he keeps them away from his old flock of sheep for a period of 15 days. This, in other w...
Effects and safety of acupuncture for DFUs: a systematic review and meta-analysis
Objective:To systematically evaluate the effect and safety of acupuncture for the treatment of diabetic foot ulcers(DFUs).Methods:Six databases, including Pubmed, Web of Science, EMbase, the Cochrane Library, the Chinese...
“Banlangen (Radix isatidis) compound granules as a treatment for COVID-19”-the market value of Baiyunshan pharmaceutical soared by 10 billion RMB
On October 13, 2020, the fourth board meeting of the Guangdong-Macau Joint Research Centre for New Drug Discovery against respiratory pathogens and the Macau Symposium on Translation of Baiyunshan Banlangen and Coopera...
Is IL1R1 required for celastrol’s leptin-sensitization and antiobesity effects?
The article by Xudong Feng et al. [1], published on 4 March 2019 in the journal of Nature Medicine, showed the relationship between natural product celastrol and obesity. The researchers demonstrated celastrol was able t...
The role of acidic microenvironment in the tumor aggressive phenotypes and the treatment
Recently, the scammer who advocated "acid constitution" as the source of all diseases was fined 105 million US dollars, and the "acid-base balance" theory he founded was also criticized. Although the "acid constitution"...